Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Owens & Minor ( (OMI) ).
On December 2, 2025, Owens & Minor announced that its management team will participate in two upcoming investor conferences, including the Citi 2025 Global Healthcare Conference in Miami and the Bank of America Leveraged Finance Conference in Boca Raton. This participation reflects the company’s ongoing efforts to engage with investors and stakeholders, potentially impacting its market positioning and investor relations.
The most recent analyst rating on (OMI) stock is a Sell with a $2.50 price target. To see the full list of analyst forecasts on Owens & Minor stock, see the OMI Stock Forecast page.
Spark’s Take on OMI Stock
According to Spark, TipRanks’ AI Analyst, OMI is a Underperform.
Owens & Minor’s overall stock score is low due to significant financial challenges, bearish technical indicators, and unattractive valuation metrics. While the earnings call highlighted some strategic initiatives, the company’s current financial instability and market momentum issues are the most significant factors impacting the score.
To see Spark’s full report on OMI stock, click here.
More about Owens & Minor
Owens & Minor, Inc. is a Fortune 500 global healthcare solutions company that provides essential products and services supporting care from hospitals to homes. With over 100 years of experience, the company, along with its affiliated brands Apria, Byram, and HALYARD, serves patients, providers, and communities worldwide, employing more than 20,000 people.
Average Trading Volume: 2,245,284
Technical Sentiment Signal: Sell
Current Market Cap: $206.5M
See more insights into OMI stock on TipRanks’ Stock Analysis page.